BioCardia, Inc. Cost of Revenue
BioCardia, Inc. (BCDA) reported Cost of Revenue of $0 for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-07-26.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2013-07-26
- BioCardia, Inc. cost of revenue for the quarter ending 2013-06-30 was $0.00.
- BioCardia, Inc. cost of revenue for the quarter ending 2013-03-31 was $0.00.
- BioCardia, Inc. cost of revenue for the quarter ending 2012-12-31 was $0.00.
- BioCardia, Inc. cost of revenue for the quarter ending 2012-09-30 was $0.00.
- BioCardia, Inc. cost of revenue for fiscal 2012 was $0.00.
- BioCardia, Inc. cost of revenue for fiscal 2011 was $0.00.
- BioCardia, Inc. cost of revenue for fiscal 2010 was $0.00.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2013-06-30 | $0.00 10-Q · filed 2013-07-26 | $0.00 10-Q · filed 2013-07-26 | $0.00 derived: sum of 3 quarters · filed 2013-07-26 | $0.00 derived: sum of 4 quarters · filed 2013-07-26 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-10 | $0.00 derived: sum of 2 quarters · filed 2013-05-10 | $0.00 derived: sum of 3 quarters · filed 2013-05-10 | $0.00 derived: sum of 4 quarters · filed 2013-07-26 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-22 | $0.00 derived: sum of 2 quarters · filed 2013-03-22 | $0.00 derived: sum of 3 quarters · filed 2013-07-26 | $0.00 10-K · filed 2013-03-22 |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-08 | $0.00 derived: sum of 2 quarters · filed 2013-07-26 | $0.00 10-Q · filed 2012-11-08 | $0.00 derived: sum of 4 quarters · filed 2013-07-26 |
| 2012-06-30 | $0.00 10-Q · filed 2013-07-26 | $0.00 10-Q · filed 2013-07-26 | $0.00 derived: sum of 3 quarters · filed 2013-07-26 | $0.00 derived: sum of 4 quarters · filed 2013-07-26 |
| 2012-03-31 | $0.00 10-Q · filed 2013-05-10 | $0.00 derived: sum of 2 quarters · filed 2013-05-10 | $0.00 derived: sum of 3 quarters · filed 2013-05-10 | $0.00 derived: sum of 4 quarters · filed 2013-05-10 |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-22 | $0.00 derived: sum of 2 quarters · filed 2013-03-22 | $0.00 derived: sum of 3 quarters · filed 2013-03-22 | $0.00 10-K · filed 2013-03-22 |
| 2011-09-30 | $0.00 10-Q · filed 2012-11-08 | $0.00 derived: sum of 2 quarters · filed 2012-11-08 | $0.00 10-Q · filed 2012-11-08 | $0.00 derived: sum of 4 quarters · filed 2012-11-08 |
| 2011-06-30 | $0.00 10-Q · filed 2012-08-10 | $0.00 10-Q · filed 2012-08-10 | $0.00 derived: sum of 3 quarters · filed 2012-08-10 | $0.00 derived: sum of 4 quarters · filed 2012-08-10 |
| 2011-03-31 | $0.00 10-Q · filed 2012-05-15 | $0.00 derived: sum of 2 quarters · filed 2012-05-15 | $0.00 derived: sum of 3 quarters · filed 2012-05-15 | $0.00 derived: sum of 4 quarters · filed 2012-05-15 |
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $0.00 derived: sum of 2 quarters · filed 2012-03-29 | $0.00 derived: sum of 3 quarters · filed 2012-03-29 | $0.00 10-K · filed 2012-03-29 |
| 2010-09-30 | $0.00 10-Q · filed 2011-11-15 | $0.00 derived: sum of 2 quarters · filed 2011-11-17 | $0.00 10-Q · filed 2011-11-15 | |
| 2010-06-30 | $0.00 10-Q/A · filed 2011-11-17 | $0.00 10-Q/A · filed 2011-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |